Search Results - Bita Lashtoo-Aghaee
- Showing 1 - 1 results of 1
-
1
Two trade names of deferasirox (Osveral® and Exjade®) in reduction of iron overload parameters in major beta-thalassemia patients: A randomized open labeled clinical trial by Mohammadreza Rafati, Hossein Karami, Bita Lashtoo-Aghaee, Bahareh Lashtoo-Aghaee, Mojdeh Dabirian, Razieh Avan
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book